Doubling the company’s footprint in Silicon Valley, a hot spot for the promising Biologics and Advanced Therapeutics area, is a testament to Biotage’s commitment and priority to continuously invest and strengthen its presence as a supplier to the Pharma and BioPharma drug discovery and development industry.

The recent global pandemic has illustrated that the development of smarter healthcare is a global need, as acknowledged by the U.N.’s sustainable development program. Biotage has recognized this trend by working to establish itself across multiple geographies, acknowledging that a commitment to HumanKind Unlimited is not restricted by location.